CAS: 51037-30-0 - Acipimox
Formula:C6H6N2O3
InChI:InChI=1S/C6H6N2O3/c1-4-2-7-5(6(9)10)3-8(4)11/h2-3H,1H3,(H,9,10)
InChI key:InChIKey=DJQOOSBJCLSSEY-UHFFFAOYSA-N
SMILES:O=C(O)C1=NC=C(N(=O)=C1)C
- Synonyms:
- 2-Pyrazinecarboxylic acid, 5-methyl-, 4-oxide
- 4-Oxo-5-Methylpyrazine-2-Carboxylic Acid
- 5-Methylpyrazine-2-Carboxylic Acid 4-Oxide
- 5-Methylpyrazinecarboxylic acid 4-oxide
- K 9321
- Olbemox
- Olbetam
- Pyrazinecarboxylic acid, 5-methyl-, 4-oxide
- Acipimox
5-Methylpyrazine-2-carboxylic Acid 4-Oxide
CAS:51037-30-0
Formula:
C6H6N2O3
Purity:
97%
Color and Shape:
Solid
Molecular weight:
154.1234
Ref: IN-DA006UPS
1g | 52.00 € | ||
5g | 81.00 € | ||
10g | 120.00 € | ||
25g | 200.00 € | ||
100g | 629.00 € | ||
500g | To inquire | ||
250mg | 25.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Acipimox
CAS:51037-30-0
Acipimox (K-9321), a niacin derivative, treats hyperlipidemia in type 2 diabetics.
Formula:
C6H6N2O3
Purity:
99.26%
Color and Shape:
Low Yellow Liquid Or Crystalline
Molecular weight:
154.12
Ref: TM-T1162
25mg | 36.00 € | ||
50mg | 47.00 € | ||
100mg | 65.00 € | ||
500mg | 142.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Acipimox
CAS:51037-30-0
Formula:
C6H6N2O3
Purity:
≥ 98.5%
Color and Shape:
White to off-white powder
Molecular weight:
154.12
Ref: 7W-GP0448
Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ref: 4Z-A-337001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Acipimox
CAS:51037-30-0
Formula:
C6H6N2O3
Purity:
>98.0%(GC)
Color and Shape:
White to Almost white powder to crystal
Molecular weight:
154.13
Ref: 3B-M2053
1g | 75.00 € | ||
5g | 211.00 € |
Estimated delivery in United States, on Thursday 9 Jan 2025
5-Carboxy-2-methylpyrazine 1-oxide
CAS:51037-30-0
Purity:
95.0%
Color and Shape:
Solid
Molecular weight:
154.125
Ref: 10-F079407
1g | 39.00 € | ||
5g | 82.00 € | ||
10g | 114.00 € | ||
25g | 217.00 € | ||
100g | 600.00 € | ||
100mg | 24.00 € | ||
250mg | To inquire |
Estimated delivery in United States, on Thursday 16 Jan 2025
Acipimox
Controlled ProductCAS:51037-30-0
Applications Antilipemic. References Fuccella, L.M., et al.: Clin. Pharmacol. Ther., 28, 790 (1980), Lovisolo, P.P., …
Formula:
C6H6N2O3
Color and Shape:
Yellow
Molecular weight:
154.12
Ref: TR-A189850
1g | 120.00 € |
Estimated delivery in United States, on Thursday 16 Jan 2025
Acipimox - Bio-X ™
CAS:51037-30-0
Acipimox is a niacin derivative that is used as a hypolipidemic agent. Acipimox prevents the …
Formula:
C6H6N2O3
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
154.12 g/mol
Ref: 3D-BA166874
100mg | 137.00 € |
Estimated delivery in United States, on Friday 17 Jan 2025
5-Methylpyrazine-2-carboxylic acid 4-oxide
CAS:51037-30-0
Niacin receptor 1 (NIACR1) antagonist; lipid lowering
Formula:
C6H6N2O3
Purity:
Min. 98 Area-%
Color and Shape:
Powder
Molecular weight:
154.12 g/mol
Ref: 3D-FM10331
5g | 180.00 € | ||
10g | 260.00 € | ||
25g | 457.00 € | ||
50g | 646.00 € | ||
100g | 986.00 € |
Estimated delivery in United States, on Friday 17 Jan 2025